Houston Chronicle

Popular Woodlands restaurant Tris suddenly shutters following chef's resignation

Despite winning the hearts of many Houstonians, food critics and even podcast host Joe Rogan, popular Woodlands steakhouse Tris is no more. The restaurant's closure was suddenly announced via its ...
FierceBiotech

Tris builds clinical case for opioid alternative by showing its pain drug is less likely to be abused

Having shown last week that its opioid alternative can reduce post-surgery pain, Tris Pharma is back with another slice of clinical data to show that the drug is less likely to be abused. The phase 1 ...
FierceBiotech

Tris' next-gen pain drug completes trio of clinical wins, setting up push to FDA

Tris Pharma’s opioid alternative has scored a third win in a trio of clinical trials, providing the biotech with the data needed to take the pain relief drug to the FDA this year. The latest readout ...
Houston Chronicle

Report: Tris chef speaks out about sudden Woodlands restaurant closure

Simmons took over the 24 Waterway Ave. space, previously the combination grocery store-restaurant Hubbel & Hudson, in 2018. Under his tenure, Tris' menu garnered critical acclaim for its modern ...
FiercePharma

Tris Pharma, a CMO for Pfizer, hit with FDA warning letter for ADHD drug, morphine solution

Tris Pharma, a New Jersey-based CMO that manufactures the ADHD drug Quillivant for Pfizer, was hit with a warning letter by the FDA that cited significant violations. In the letter dated March 26, the ...
Business Wire

Tris Pharma Announces Positive Results from ALLEVIATE-2 Phase 3 Pivotal Trial for Cebranopadol, an Investigational First-in-Class Oral Dual-NMR Agonist, for the Treatment of ...

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ALLEVIATE-2 Phase 3 pivotal clinical ...